Jean Fallacara Joins Jupiter Neurosciences as Nugevia Brand Ambassador
ByAinvest
Monday, Sep 15, 2025 8:06 am ET1min read
JUNS--
Fallacara's career spans over three decades, during which he has founded and led multiple ventures, including Z-Sciences, which was acquired by NYSE American-listed inTEST Corp in 2021 [1]. He is also the founder of Lifespanning Media, a platform dedicated to extending and enriching human lifespan through science, art, health, and technology [1].
Nugevia™ is built on Jupiter's patented resveratrol-based micellar delivery platform, JOTROL™, which has demonstrated significantly enhanced bioavailability [1]. The product line includes three formulations—GLO, MND, and PWR—that are designed to support cellular resilience. This consumer initiative is part of Jupiter's dual-path strategy, targeting the longevity market projected to reach $8 trillion by 2030 while supporting their clinical development programs [1].
The appointment of Fallacara is expected to bring clinical and scientific integrity to Nugevia's launch in the fast-growing longevity space [1]. "Jean embodies the principles at the heart of Nugevia™: longevity, resilience, and human optimization supported by real science," said Christer Rosén, Chairman and CEO of Jupiter Neurosciences [1]. Fallacara commented, "Resveratrol has always been an overlooked cornerstone of longevity, as essential as NAD or NMN. Nugevia™ takes this breakthrough molecule and finally unlocks its full potential, merging real science with wellness innovation to deliver energy, focus, and cellular health for anyone striving to live and perform at their best" [1].
Jupiter Neurosciences is a clinical-stage pharmaceutical company pursuing a dual-path strategy to address neuroinflammation and promote healthy aging [1]. The company is advancing a therapeutic pipeline targeting central nervous system (CNS) disorders and rare diseases, while also expanding into the consumer longevity market with its Nugevia™ product line. Both efforts are powered by JOTROL™, Jupiter's proprietary, enhanced resveratrol formulation that has demonstrated significantly improved bioavailability [1].
Jean Fallacara, a renowned neuroscientist and biohacker, has joined Jupiter Neurosciences as a brand ambassador for Nugevia, a new consumer longevity supplement line. Fallacara is recognized globally for his work in biohacking, biotechnology, and human performance, and has founded and led several ventures, including Z-Sciences, which was acquired by inTEST Corp in 2021. He will bring clinical and scientific integrity to Nugevia's launch in the fast-growing longevity space.
Jupiter Neurosciences, Inc. (NASDAQ: JUNS) has named Jean Fallacara, a renowned entrepreneur and neuroscientist, as the third brand ambassador for their consumer longevity supplement line, Nugevia™ [1]. Fallacara, known for his pioneering work in biohacking, biotechnology, and human performance, brings extensive experience and a track record of innovation to the role. He is recognized as one of the "Most Disruptive Entrepreneurs 2023" and a "Top Biohacking Influencer 2022" [2].Fallacara's career spans over three decades, during which he has founded and led multiple ventures, including Z-Sciences, which was acquired by NYSE American-listed inTEST Corp in 2021 [1]. He is also the founder of Lifespanning Media, a platform dedicated to extending and enriching human lifespan through science, art, health, and technology [1].
Nugevia™ is built on Jupiter's patented resveratrol-based micellar delivery platform, JOTROL™, which has demonstrated significantly enhanced bioavailability [1]. The product line includes three formulations—GLO, MND, and PWR—that are designed to support cellular resilience. This consumer initiative is part of Jupiter's dual-path strategy, targeting the longevity market projected to reach $8 trillion by 2030 while supporting their clinical development programs [1].
The appointment of Fallacara is expected to bring clinical and scientific integrity to Nugevia's launch in the fast-growing longevity space [1]. "Jean embodies the principles at the heart of Nugevia™: longevity, resilience, and human optimization supported by real science," said Christer Rosén, Chairman and CEO of Jupiter Neurosciences [1]. Fallacara commented, "Resveratrol has always been an overlooked cornerstone of longevity, as essential as NAD or NMN. Nugevia™ takes this breakthrough molecule and finally unlocks its full potential, merging real science with wellness innovation to deliver energy, focus, and cellular health for anyone striving to live and perform at their best" [1].
Jupiter Neurosciences is a clinical-stage pharmaceutical company pursuing a dual-path strategy to address neuroinflammation and promote healthy aging [1]. The company is advancing a therapeutic pipeline targeting central nervous system (CNS) disorders and rare diseases, while also expanding into the consumer longevity market with its Nugevia™ product line. Both efforts are powered by JOTROL™, Jupiter's proprietary, enhanced resveratrol formulation that has demonstrated significantly improved bioavailability [1].
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet